Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72- 4 immunoassay

Cancer Research

Volumn 56, Issue 22, 1996, Pages 5293-5298

  Guadagni, Fiorella ^a   Roselli, Mario ^b   Cosimelli, Maurizio ^a   Spila, Antonella ^a   Cavaliere, Francesco ^a   Tedesco, Manfredo ^a   Arcuri, Raffaella ^a   Abbolito, Maria Rosaria ^a   Casale, Vincenzo ^a   Pericoli, Maria Nicoletta ^a   Vecchione, Aldo ^c   Casciani, Carlo U ^b   Greiner, John W ^d   Schlom, Jeffrey ^d  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GLYCOPROTEIN; MONOCLONAL ANTIBODY B.72.3;

ARTICLE; BIOPSY; COLON MUCOSA; COLORECTAL CANCER; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOGENICITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SECRETORY CELL; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; COLORECTAL NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM PROTEINS;

EID: 10544255082     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Colcher, D., Horan Hand, P., Nuti, M., and Schlom, J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells Proc. Natl. Acad. Sci. USA, 78, 3199-3203, 1981.
2. Nuti M., Teramoto, Y. A., Mariani-Costantini, R., Horan Hand, P., Colcher, D., and Schlom, J. A monoclonal antibody (B72 3) defines pattern of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations. Int. J. Cancer, 29, 539-545, 1982.
3. Stramignoni, D., Bowen, R., Atkinson, B. F., and Schlom, J. Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas. Int. J. Cancer, 31: 543-552, 1983.
4. Thor, A., Ohuchi, N., Szpak, C. A., Johnston, W. W., and Schlom, J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res., 46: 3118-3124, 1986.
5. Mazur, M. T., and Shultz, J. J. Prostate adenocarcinoma. Evaluation of immunoreactivity to monoclonal antibody B72 3. Am. J. Clin Pathol., 93: 466-470, 1990.
6. Ohuchi, N., Thor, A., Nose, M., Fujita, J., Kyogoku, M., and Schlom, J. Tumor-associated glycoprotein (TAG-72) detected in adenocarcinoma and benign lesions of the stomach. Int. J. Cancer, 38: 643-650, 1986.
7. Xu, M., Real, F. X., Welt, S., Schussler, M. H., Oettgen, H. F., and Old, L. J. Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer Int. J. Cancer, 44: 985-989, 1989.
8. Thor, A., Viglione, M. J., Muraro, R., Ohuchi, N., Schlom, J., and Gorstein, F. Monoclonal antibody B72 3 reactivity with human endometrium: a study of normal and malignant tissues Int. J. Gynecol. Pathol., 6: 235-247, 1987.
9. Kjeldsen, T., Clausen, H., Hirohashi, S., Ogawa, T., Iijma, H., and Hakomon, E. S. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6α-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res., 48: 2214-2220, 1988.
10. Kuroki, M., Fernsten, P. D., Wunderlich, D., Colcher, D., Simpson, J. F., Poole, D. J., and Schlom, J. Serologic mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies. Cancer Res., 50: 4872-4879, 1990.
11. 111In-CYT-103). Antibody Immunoconj Radiopharm., 2, 257-269, 1989.
12. Winzelberg, G. G., Grossman, S. J., Rizk, S., Jyoce, J. M., Hill, J. B., Atkinson, D. P., Sudina, K., Anderson, K., McElwain, D., and Jones, A. Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer. Cancer (Phila.), 69: 1656-1663, 1992.
13. Martin, E. W., Jr., Tuttle, S. E., Rousseau, M., Mojzisik, C. D., O'Dwyer, P. J., Hinkle, G. H., Miller, E. A., Goodwin, R. A., Oredipe, O. A., Barth, R. F. Olsen, J. O., Houchens, D., Jewell, S. D., Bucci, D. M., Adams, D., Steplewski, Z., and Hurston, M. O. Radioimmunoguided surgery: intraoperative use of monoclonal antibody 171-A in colorectal cancer Hybridoma, 5: S97-S108, 1986.
14. Arnold, M. W., Schneebaum, S., Berens, A., Mojzisik, C., Hinkle, G., and Martin, E. W., Jr. Radioimmunoguided surgery challenges traditional decision making in primary colorectal cancer Surgery (St Louis), 112: 624-630, 1992.
15. Kostakoglu, L., Divigi, C. R., Hilton, S., Cordon-Cardo, C., Scott, A. M., Kalaigian, H., Finn, R. D., and Larson, S. M. Pre-selection of patients with high TAG-72 antigen expression leads to targeting 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49. Cancer Invest., 12: 551-558, 1994.
16. Esteban, J. M., Colcher, D., Sugarbaker, P., Carrasquillo, J. A., Bryant, G., Thor, A., Reynolds, J. C., Larson, S. M., and Schlom, J. Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3. Int. J. Cancer, 39: 50-59, 1987.
17. Colcher, D., Esteban, J. M., Carrasquillo, J. A., Sugarbaker, P., Reynolds, J. C., Bryant, G., Larson, S. M., and Schlom, J. Quantitative analyses of selective radiolabeled monoclonal antibody localization in metastatic lesion of colorectal cancer patients. Cancer Res., 47: 1185-1189, 1987.
18. Carrasquillo, J. A., Sugarbaker, P., Colcher, D., Reynolds, J. C., Esteban, J., Bryant, G., Keenan, A. M., Perentesis, P., Yokoyama, K., Simpson, D. E., Ferroni, P., Farkas, R., Schlom, J., and Larson, S. M. Radioimmunoscintigraphy of colon cancer with I-131-labeled B72.3 monoclonal antibody. J. Nucl. Med., 29: 1022-1030, 1988.
19. Schlom, J., Colcher D., Roselli M., Carrasquillo, J. A., Reynolds, J. C., Larson, S. M., Sugarbaker, P., Tuttle, S. E., and Martin, E. W., Jr. Tumor targeting with monoclonal antibody B72.3. Nucl. Med Biol., 16: 137-142, 1989.
20. Gero, E. J., Colcher, D., Ferroni, P., Melsheimer, R., Giani, S., Schlom, J., and Kaplan, P. The CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma associated antigen in serum of patients J. Clin Lab. Anal., 3: 360-369, 1989.
21. Ohuchi, N., Takahashi, K., Matoba, Y., Sakai, N. Masuda, M., and Mori, S. Comparison of serum assay for TAG-72, CA 19-9, and CEA in gastrointestinal carcinoma patients Jpn J. Clin. Oncol., 19: 242-248, 1989.
22. Guadagni, F., Roselli, M., Amato, T., Cosimelli, M., Perri, P., Casale, V., Carlini, M., Santoro, E., Cavaliere, R., Greiner, J. W., and Schlom, J. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma. Cancer Res., 52: 1222-1227, 1992.
23. Guadagni, F., Marth, C., Zeimet, A. G., Ferroni, P., Spila, A., Roselli, M., Greiner, J. W., and Schlom, J. Evaluation of CA 72-4 and CA 125 in patients with gynecological diseases. Am. J. Obstet. Gynecol., 11: 1183-1191, 1994.
24. Guadagni, F., Roselli, M., Cosimelli, M., Mannella, E., Tedesco, M., Cavaliere, F., Grassi, A., Abbolito, M. R., Greiner, J. W., and Schlom, J. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring colorectal cancer patients. Cancer (Phila), 72: 2098-2106, 1993.
25. Guadagni, F., Roselli, M., Cosimelli, M., Ferroni, P., Spila, A., Cavaliere, F., Casaldi, V., Wappner, G., Abbolito, M. R., Greiner, J. W., and Schlom, J. CA 72-4 serum marker - a new tool in the management of carcinoma patients. Cancer Invest., 13: 227-238, 1995.
26. MacLean, G. D., Reddish, M., Koganty, R. R., Wong, T., Gandhi, S., Smolenski, M., Samuel, J., Nabholtz, J. M., and Longenecker, B. M. Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus detox adjuvant. Cancer Immunol. Immunother., 36: 215-222, 1993.
27. Kobayashi, H., Terao, T., and Kawashima, Y. Serum sialyl-Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer. J. Clin. Oncol., 10: 95-101, 1992.
28. Takahashi, I., Maehara, Y., Kusumoto, T., Yoshida, M., Kakeji, Y., Kusumoto, H., Furusawa, M., and Sugimachi, K. Predictive value of preoperative serum sialyl-Tn antigen levels in prognosis of patients with gastric cancer. Cancer (Phila.), 72: 1836-1840, 1993.
29. Takahashi, I., Maehara, Y., Kusumoto, T., Kohnoe, S., Kakeji, Y., Baba, H., and Sugimachi, K. Combined evaluation of preoperative serum sialyl-Tn antigen and carcinoembryonic antigen levels is prognostic for gastric cancer patients Br. J. Cancer, 69: 163-166, 1994.
30. Victorzon, M., Nordling, S., Nilsson, O., Roberts, P. J., and Haglund, C. Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer. Int. J. Cancer, 65: 295-300, 1996.
31. Itzkowitz, S. H., Bloom, E. I., Kokal, W. A., Modin, G., Hakomori, S., and Kim, S. Y. Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer (Phila.), 66, 1960-1966, 1990.
32. Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
33. Molinolo, A., Simpson, J. F., Thor, A., and Schlom, J. Enhanced tumor binding using immunohistochemical analyses by second-generation anti-tumor associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue. Cancer Res., 50: 1291-1298, 1990.
34. Wolf, B. C., D'Emilia, J. C., Salem, R. R., DeCoste, D., Sears, H. F., Gottlieb, L. S., and Steele, G. D., Jr. Detection of the tumor-associated glycoprotein antigen (TAG-72) in premalignant lesions of the colon. J. Natl. Cancer Inst., 81: 1913-1917, 1989.
35. 177Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma. Clin. Cancer Res., 1: 1447-1454, 1995.